Expand BMEA Menu
BMEA MENU

BMEA Latest Press Releases

-- May 12, 2026 --

Biomea Fusion to Participate at Upcoming Investor Conferences Globe Newswire 4:05 PM

-- May 11, 2026 --

Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights Globe Newswire 4:54 PM

-- May 5, 2026 --

Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions Globe Newswire 5:50 PM

-- April 27, 2026 --

Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment Globe Newswire 5:37 PM

-- March 31, 2026 --

Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies Globe Newswire 7:00 AM

-- March 24, 2026 --

Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights Globe Newswire 4:05 PM

-- March 14, 2026 --

Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026 Globe Newswire 4:30 AM

-- February 19, 2026 --

Biomea Fusion to Participate at Upcoming Investor Conferences Globe Newswire 7:00 AM

-- January 12, 2026 --

Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones Globe Newswire 8:00 AM

-- December 17, 2025 --

Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes